Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Conflict of Interest Policy & Form for Human Research at North Texas Regional IRB, Study notes of Technology

Human Subject ProtectionConflict of InterestResearch EthicsInstitutional Review Board

The conflict of interest (coi) policy and statement of the north texas regional institutional review board (irb) for the protection of human subjects in research. It includes a coi disclosure statement and form that must be completed, signed, and submitted with each initial and continuing application for irb review. The policy aims to enable individuals to recognize and resolve situations that may be subject to question and avoid conflicts of interest.

What you will learn

  • What types of financial interests must be disclosed in the COI Disclosure Statement and Form?
  • What is the Conflict of Interest Policy and Statement of the North Texas Regional Institutional Review Board?
  • What is the procedure for submitting a COI Disclosure Statement and Form to the North Texas Regional IRB?

Typology: Study notes

2021/2022

Uploaded on 09/12/2022

shekara_44het
shekara_44het 🇺🇸

4.3

(7)

5 documents

1 / 3

Toggle sidebar

Related documents


Partial preview of the text

Download Conflict of Interest Policy & Form for Human Research at North Texas Regional IRB and more Study notes Technology in PDF only on Docsity! IRB Conflict of Interest Form Rev. 01/2018 IRB CONFLICT OF INTEREST POLICY AND STATEMENT For the protection of human subjects, the North Texas Regional Institutional Review Board (IRB) has adopted the following Conflict of Interest (COI) Policy and Statement. Each protocol submitted to North Texas Regional Institional Review Board (IRB) for review must be accompanied by a COI Disclosure Statement for each person who is directly involved in research activities and/or interacting with research subjects in the covered study. NOTE: Each protocol must be accompanied by all appropriate COI Statements. This policy is effective May 8, 2015 and is part of the IRB protocol review process. Protocols submitted without the appropriate COI Statements will not be accepted or reviewed until all appropriate COI documents are received. COI Statements MUST be completed, signed and submitted with each Initial and Continuing Application for IRB Review. Note that this North Texas Regional IRB Conflict of Interest Statement is independent of the UNTHSC Research Conflict of Interest requirement. Other forms may be required for other units within the university (e.g., Grants and Contracts / Sponsored Programs) and other insititutions. These are all separate documents/processes. If you have any further questions, please call the Office of Research Compliance (ORC) - North Texas Regional IRB at 817-735-0409. IRB CONFLICT OF INTEREST POLICY PURPOSE - Public trust in the research enterprise and the legitimacy of its powerful role in society require a constant amenability to public scrutiny. Consequently, it is necessary at all times to assure the continued confidence of the public in the judgment of scholars and clinicians and in the dedication of academic research institutions to the integrity of the research enterprise. The strength of this assurance is based on the assumption that scholars are honest and conduct their research with the highest standards and integrity. This policy is intended to serve subjects of human research. This policy is not intended to eliminate all situations of conflict of interest, but rather to enable individuals to recognize situations that may be subject to question and resolve them so as to avoid conflicts of interest. Thus an integral part of the policy is disclosure whereby individuals regularly review their professional activities. THE POLICY - Individuals directly involved in the conduct, design or reporting of research involving human subjects should not have more than a minimal personal financial interest in a company that sponsors the research or owns the technology being studied. A conflict of interest arises when a researcher is or may be in a position to put his or her own interest before the best interests of research subjects. Conflicts involving the IRB itself or conflicts involving the institution must be managed. In order to manage such conflicts, the IRB must be informed of potential conflicts of interest. Researchers submitting protocols using human subjects must disclose all interests that may be perceived as a conflict with the best interest of the subject in order for the research to be considered for approval. IRB Conflict of Interest Form Rev. 01/2018 IMPLEMENTATION: A. Researchers who have completed Financial Disclosure forms required by the FDA to be submitted to a sponsor of the research may submit a copy of that form to the IRB. B. Researchers who have not completed the form required by the FDA must complete and submit the IRB Form attached to this policy. C. Based on the information submitted by the researcher for review, the IRB may determine that: 1. no conflict exists, or 2. a conflict exists and must be disclosed to the subjects in the informed consent statement, or 3. a conflict exists and the researcher must resolve the conflict before the research can be approved. EXAMPLES OF REPORTABLE AND NON-REPORTABLE ACTIVITIES 1. Non-Reportable Activities The following activities and relationships do not need to be reported and do not represent a conflict of interest because they have been generally accepted practices and do not violate fundamental ethical principles. a. Receiving royalties for published scholarly works and other writings. b. Accepting honoraria for commissioned papers and occasional lectures. c. Receiving payment for reasonable travel and lodging expenses related to presentations of scholarly work or to a person’s academic endeavor. d. Investing in mutual funds. e. Participating in a University approved practice corporation. f. Payments for clinical research to an approved practice corporation or to a department fund for salary or other expenses of conducting clinical trials. 2. Reportable Activities a. Conducting research in applied and/or clinical research on a technology developed by the investigator or a member of his/her immediate family (spouse, children, parent, in-laws, siblings). b. The financial relationship of an investigator or his/her immediate family member with the sponsor of his/her research (acting as scientific advisor or consultant, or receiving honoraria exceeding $5,000 annually, or acting as director or other executive). c. Conducting applied and/or clinical research on a technology owned by a business in which the investigator or a member of his/her immediate family holds 5% or more of the outstanding stock or stock options. d. Receiving royalties under institutional royalty-sharing policies from marketing the drug, device or procedures that is the subject of the research. e. Receiving payments directly from the sponsor, rather than through John Peter Smith, the University or an approved UNTHSC entity, for recruiting subjects. Effective May 8, 2015
Docsity logo



Copyright © 2024 Ladybird Srl - Via Leonardo da Vinci 16, 10126, Torino, Italy - VAT 10816460017 - All rights reserved